Global Paclitaxel Market Overview:
Paclitaxel is an antineoplastic agent which acts by an inhibitor of cellular mitosis and it is used in chemotherapy medications for the treatment of various types of cancer. It is primarily being used for the treatment of ovarian, breast, and lung cancer. Therapy with paclitaxel has been linked with a low rate of serum enzyme elevations however has not been clearly linked to cases of clinically apparent acute liver injury. The drug was isolated from the bark of the Pacific yew tree. Owing to the rising prevalence of cancer, the demand for paclitaxel has surged across the globe. Some of the key players profiled in the study are Phyton Biotech (Canada), ScinoPharm (Taiwan), Novasep Inc. (United States), Samyang (Korea), Polymed (United States), TAPI (Teva) (United Kingdom), Fresenius-kabi (Germany), Southpharma (Serbia), Haiyao (China) and Huiang Biopharma (China).
On the basis of geography, the market of Paclitaxel has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Asia Pacific on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Paclitaxel market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The Use of Paclitaxel in Treating Various Types of Cancer with High Efficiency and Positive Results
- Increase in the Incidences of Cancer Diseases
- The Ease in Availability of Paclitaxel and Development of This Drug
- Advanced Technologies and Awareness towards the Treatments
- The Adverse Effects with Usage of This Drug and Various Side Effects
- Emerging Demand from Economies
Target Audience:Paclitaxel Manufactures, Paclitaxel Distributors, Paclitaxel Importer/Exporter, Research & Consultant Firms, Regulatory & Government Bodies and Downstream Vendors
Major Objectives Focused through this Study To define, describe, and forecast the Global Paclitaxel market on the basis of product [Natural Paclitaxel and Semi-synthetic Paclitaxel] , application [Breast Cancer, Ovarian Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, Stomach Cancer and Others], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Paclitaxel market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Paclitaxel industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Yunnan Hande (China) and Hainan Yew Pharm (China).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Paclitaxel market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.